tiprankstipranks
Helius Medical Explores Strategic Alternatives Amid Challenges
Company Announcements

Helius Medical Explores Strategic Alternatives Amid Challenges

Pick the best stocks and maximize your portfolio:

Helius Medical Technologies ( (HSDT) ) just unveiled an update.

Helius Medical Technologies is actively pursuing strategic alternatives to enhance shareholder value amid challenges with CMS pricing determinations for its PoNS device. Having engaged B. Riley Securities as an advisor, the company is exploring options like mergers or sales, while also addressing reimbursement issues to better position its innovative neuromodulation therapy in the market.

For a thorough assessment of HSDT stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskHelius Medical Technologies Reports Q3 2024 Earnings
TheFlyHelius Medical provides update on PoNS device pricing regulation
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App